Closed holtgrewe closed 9 months ago
see Methods > Criteria and Scoring System
Criteria | Rule |
---|---|
PVS1 | Null variants on canonical transcript for 4807 identified LOF-intolerant gene list, before 50 nucleotides of final exon-junction complex |
PS1 | Automatic match against list of ClinVar pathogenic missense-variants, same AA change |
PS4 | Variants with OR > 5.0 in GWASdb v2 |
PM1 | domain info from dbnsfp31a_interpro database, list of domains with only pathogenic and likely pathogenic variants based on ClinVar data |
PM2 | absent in ESP6500, 1000 Genomes, ExAC for dominant or AAF <0,5% for recessive |
PM4 | non-frameshift insertion/deletion, stop-loss in non-repeat regions (rmsk database UCSC browser) |
PM5 | Automatic match against list of ClinVar pathogenic missense-variants, different AA change |
PP2 | >80% pathogenic (at least one) clinvar variants missense and <10% benign (and less than one) |
PP3 | dfnsfp30a MetaSVM (>0, deleteriousness), GERP++ (>2.0, conservation), dbscnv11 (>0.6 ADA, RF scores) |
PP5 | ClinVar or HGMD as database |
BA1 | AAF > 5% |
BS1 | AAF > 1% (default cutoff, user-adjustable) |
BS2 | hom (for AR) or het (for AD) in 1000 Genomes |
BP1 | >80% pathogenic (at least one) clinvar variants truncating |
BP3 | non-frameshift insertion, non-frameshift deletion in repeat region (defined by rmsk database) |
BP4 | Evidence (see PP3) does not suggest impact |
BP6 | ClinVar or HGMD as database |
BP7 | dbscnv RF and ADA <0.6, GERP++ <2 (not conserved) |
PS2, PM6 - de novo status of variant PS3, BS6 - functional studies PM3, BP2 - variant in cis/trans with known pathogenic PP1, BS4 - familial segregation PP4 - phenotype and family history BP5 - alternative molecular basis
Section | Evidence | Rule |
---|---|---|
1 | 1A | 0 otherwise |
1B | -0.6 if no protein coding genes or functionally important elements | |
2 | 2A | 1 if del spans haploinssuficient or dup spans triplosensitive gene or region (clingen database) |
2B | 0 no overlap | |
2C | 0.9 if exon involved or 0.0 without for partial 5' overlap | |
2D | 0.9 for 3' overlap if pathogenic variants documented in exon (P/LP ClinVar /w AF <1% gnomAD), 0.3 without known pathogenic, 0.9 multiple exons | |
2E | AutoPVS1, 0.9 if NMD, 0.45 if altered region critical, 0.45 if >10% protein removed, 0.3 <10% protein | |
2F | -1 if established benign genes, regions | |
2G | 0 if established benign genes but includes additional regions | |
2H | 0.15 gene pLI >=0.9 and Decipher HI <=10% | |
2I | dups AutoPVS1, 0.9 if tandem + NMD, 0.45 if tandem | |
2L | dups 0 genes without clinical significance | |
3 | 3A | 0 otherwise |
3B | 0.45 del 25-34 or dup 35-49 protein coding genes | |
3C | 0.9 for del >35 and dup >50 protein coding genes | |
4 | 4O | -1 if CNV entirely within common variation (DGV Freq >=1% or gnomAD >=1%), or if overlap >50% without containing other protein coding genes |
Section 2 - 2J, 2K - patient phenotype consistency with LOF of gene Section 4 - 4A-N - phenotype, segregation in literature, case control Section 5 - 5A-5H - patient phenotype, family segregation
@holtgrewe @gromdimon @sczakihl I have added a table and written a brief text in the comparison section of the paper. Just realized that the CNV rule numbering greatly differs between dels and dups. So the current table is a bit incomplete.
@xiamaz will you update the table here as well?
@holtgrewe Which table do you refer to?
So the current table is a bit incomplete.
@xiamaz this one ;-)
@holtgrewe Only if you actually need that info in a figure, as the AutoCNV paper is not very clear on some details.
@xiamaz can you take over #440 and fill out the missing information and review the existing one
Is your feature request related to a problem? Please describe. We currently do not explain well the ACMG criteria filled out by InterVar and AutoCNV.
Describe the solution you'd like We should both summarize the criteria and refer to the InterVar and AutoCNV publications.
Describe alternatives you've considered N/A
Additional context N/A